Lipopolysaccharide or LPS is localized to the outer leaflet of the outer membrane and serves as the major surface component of the bacterial cell envelope. This remarkable glycolipid is essential for virtually all Gram-negative organisms and represents one of the conserved microbial structures responsible for activation of the innate immune system. For these reasons, the structure, function, and biosynthesis of LPS has been an area of intense research. The LPS of a number of bacteria is composed of three distinct regions -lipid A, a short core oligosaccharide, and the O-antigen polysaccharide. The lipid A domain, also known as endotoxin, anchors the molecule in the outer membrane and is the bioactive component recognized by TLR4 during human infection. Overall, the biochemical synthesis of lipid A is a highly conserved process; however, investigation of the lipid A structures of various organisms shows an impressive amount of diversity. These differences can be attributed to the action of latent enzymes that modify the canonical lipid A molecule. Variation of the lipid A domain of LPS serves as one strategy utilized by Gram-negative bacteria to promote survival by providing resistance to components of the innate immune system and helping to evade recognition by TLR4. This review summarizes the biochemical machinery required for the production of diverse lipid A structures of human pathogens and how structural modification of endotoxin impacts pathogenesis.
INTRODUCTION
Unlike Gram-positive organisms, Gram-negative bacteria are further guarded from their environment by an asymmetric outer membrane that encapsulates their peptidoglycan. The outer leaflet of the outer membrane is composed primarily of lipopolysaccharide (LPS), a unique glycolipid that serves as the major surface molecule of Gram-negative bacteria, whereas the inner leaflet is composed of phospholipids. 1 The LPS, also referred to as endotoxin, of Escherichia coli and other members of the Enterobacteriaceae family, is organized into three structural domains -O-antigen, core, and lipid A (Fig. 1 ). 2 Lipid A is a glucosamine-based lipid that serves as the hydrophobic anchor of LPS and is the bioactive component of the molecule associated with Gram-negative septic shock. [2] [3] [4] LPS is present on the surface of Gram-negative bacteria and represents one of the microbial molecular signals responsible for activation of the innate immune system. The term endotoxin was first introduced by Richard Pfeiffer in his description of a heat-stable, non-proteinaceous, nonsecreted, toxin of Vibrio cholerae that was 'closely attached to, and probably an integral part of, the bacterial body'. 5, 6 Dissociated LPS is recognized by the innate immune system by the pattern-recognition receptor TLR4 (Toll-like receptor 4) that is present on many cell types including macrophages and dendritic cells. 7, 8 Initially, the presence of LPS is sensed by the serum LPS-binding protein (LBP) which delivers the macromolecule to CD14. 9,10 CD14 is either soluble or bound to the surface of the host cell via a GPI-anchor and presents LPS to TLR4 along with the required accessory molecule MD-2. 11 Again, only the lipid A domain of LPS is required to elicit an immune response. In limited infections, the response to endotoxin is beneficial, helping to clear the invading microbe. Conversely, in overwhelming sepsis, high levels of circulating cytokines Fig. 1 . Regulated chemical structure of the inner core and lipid A domains of S. typhimurium LPS. LPS is composed of lipid A, core oligosaccharide, and O-antigen. The core oligosaccharide can be further subdivided into the inner and outer core, with the inner region proximal to the lipid A domain comprised of the Kdo and heptose sugars. PhoP-regulated modifications effecting lipid A acylation are shown in blue and PmrA-regulated modifications effecting the overall charge of the molecule are shown in red. Modifications that are regulated by the presence of Ca 2+ are shown in green. Other modifications to the structure that are present under normal laboratory conditions are shown in black. and procoagulant activity may damage the microvasculature and precipitate the syndrome of septic shock. 12, 13 Since not all Gram-negative pathogens produce a lipid A structure capable of TLR4 activation, the host response to the presence of endotoxin is dependent on both the severity of infection and to the lipid A structure of the invading microbe. A number of pathogens producing significant human disease synthesize lipid A molecules that are poorly recognized by human TLR4. 14 Examples include the lipid A of Helicobacter pylori, 15, 16 Yersinia pestis, 17, 18 Francisella tularensis, 19, 20 Legionella pneumophila, 21 Porphyromonas gingivalis 15, 22 and Chlamydia trachomatis. 23 Interestingly, the lipid A of some of the aforementioned organisms shows TLR4 antagonistic properties and/or activates TLR2, a pattern recognition receptor sensing the presence of bacterial lipoprotein. 24, 25 Key determinants of the lipid A structure promoting TLR4 activation include the phosphate groups and the length and number of fatty acyl chains. 17, [26] [27] [28] The prototypical lipid A of E. coli, containing two phosphate groups and six acyl chains composed of 12-14 carbons, is a powerful activator of the innate immune system. 3, 17 Over 20 years ago, the laboratory of Christian R.H. Raetz reported the discovery of a membrane-associated glycolipid in E. coli known as lipid X, a monosaccharide precursor of lipid A. 29, 30 This initial discovery led to the elucidation of the lipid A biosynthetic pathway sometimes referred to as the 'Raetz pathway' (Fig. 2 ). 31 In 2002, the last of the lpx genes was cloned completing the biosynthetic pathway. 32 Bioinformatic analysis reveals that the constitutive lipid A pathway is highly conserved among Gram-negative bacteria, though numerous Gramnegative bacteria are known to modify their lipid A structure. Over the last 10 years, the identification and regulation of lipid A modifying genes has been an exciting and integral part of lipid A research. The intent of this review is to discuss the conserved features of lipid A biosynthesis and how the enzymatic modification of lipid A impacts the pathogenesis of Gram-negative bacteria associated with human disease.
BIOSYNTHESIS OF LIPID A

The Raetz pathway
The lipid A of E. coli and Salmonella typhimurium is a β-1-6-linked disaccharide of glucosamine, phosphorylated at positions 1-and 4′-, and acylated at the 2-, 3-, 2′-, and 3′-positions of the disaccharide with β-hydroxymyristate (3-OH-C14:0). The hydroxy groups of the 2′-and 3′-linked fatty acyl chains are further esterified with laurate (C12:0) and myristate (C14:0), respectively, and the molecule is glycosylated at the 6-position with two Kdo (3-deoxy-D-manno-octulosonic acid) moieties ( Fig. 1 ). In wild-type strains, the core sugars and O-antigen polysaccharide chain are attached to the inner Kdo ( Fig. 1 ). 33 Typical E. coli K-12 laboratory strains do not contain the O-antigen region of LPS. 34, 35 Lipid A is required to maintain the integrity of the outer membrane barrier 36, 37 and the minimal structure required for E. coli cell growth under normal laboratory conditions is the Kdo-modified, hexa-acylated lipid A. 2, 33 However, the polysaccharide core and O-antigen regions of LPS are important for antibiotic resistance, evasion of the complement system, and for the survival of various environmental stresses. 38 The biosynthetic pathway of E. coli lipid A is shown in Figure 2 and is discussed here.
The pathway begins in the cytoplasm of the cell with the acylation of the sugar nucleotide UDP-N-acetylglucosamine (UDP-GlcNAc), a precursor of both peptidoglycan and lipid A. LpxA transfers a β-hydroxymyristate to the 3-OH of UDP-GlcNAc utilizing an acyl-acyl carrier protein (acyl-ACP) as the acyl-donor. 37, 39 The second step and the first committed step of lipid A biosynthesis is catalyzed by the zinc metalloenzyme LpxC. 40, 41 LpxC de-N-acetylates UDP-monoacyl-GlcNAc providing a free amino group for the addition of a second β-hydroxymyristate catalyzed by LpxD. LpxD shows significant sequence homology to LpxA and, like LpxA, utilizes ACP thioesters as the obligate acyl-donor. 42, 43 A portion of the LpxD product, UDP-2,3-diacylglucosamine, is cleaved at the pyrophosphate bond by LpxH yielding UMP and 2,3-diacylglucosamine 1-phosphate. 32, 44 The latter is referred to as lipid X (Fig. 2) , and its discovery provided critical insights into the synthesis of lipid A. 29, 45 Formation of the characteristic β-(1′-6)-glycosidic linkage present in all lipid A molecules is catalyzed by LpxB, the disaccharide synthase. LpxB condenses one molecule of UDP-2,3-diacylglucosamine with one molecule of lipid X, with lipid X serving as the acceptor molecule and providing the origin of the 1-phosphate group of lipid A. 46 Up until the formation of the lipid A disaccharide backbone, the lipid A biosynthetic enzymes are cytosolic and do not require detergent for activity in in vitro assays. The enzymatic steps catalyzed by LpxK, WaaA, LpxL, and LpxM all require non-ionic detergents for activity in vitro and are membrane bound. Furthermore, these reactions all require cytosolic factors for activity and, therefore, occur at the cytoplasmic face of the inner membrane ( Fig. 2 ). LpxK, a specific kinase, catalyzes the phosphorylation of the 4′-hydroxyl group producing a key lipid A precursor, lipid IV A . 47, 48 In E. coli, this is followed by the addition of two Kdo sugars catalyzed by WaaA, formerly KdtA, representing the first step of core biosynthesis. 49 The Kdo transferases of some organisms, such as Vibrio spp. 50 and Haemophilus spp., 51 transfer a single Kdo sugar to the disaccharide backbone, whereas in Chlamydia spp., WaaA can be tri-or even tetra-functional. 52, 53 It remains unknown how the functionality of the Kdo transferases from various organisms is determined. Addition of the two secondary acyl chains completes the lipid A biosynthetic pathway in E. coli and Salmonella spp. and occurs only after the addition of the Kdo sugars. [54] [55] [56] The socalled 'late' or secondary acyltransferases, LpxL (HtrB) and LpxM (MsbB), catalyze the transfer of laurate (C12:0) and myristate (C14:0), respectively. Again, acyl-ACPs serve as the obligate acyl-donors. However, the late acyltransferases show absolutely no homology to LpxA or LpxD. [56] [57] [58] Since lipid A is generally required for bacterial growth, inhibitory agents targeting its synthesis have been investigated for the production of new antimicrobials. Inhibition of any of the first seven steps of the pathway in E. coli leads to cell death; therefore, only conditional mutants been isolated for the early steps of the pathway. 2 The crystal structure of LpxA was reported in 1995, 59 but no candidate inhibitors of this step of lipid A biosynthesis have been reported. However, much progress has been made in the production of inhibitors targeting the Zn 2+ -dependent deacetylase, LpxC. Since this enzyme is highly conserved in Gram-negative bacteria and has no homology to mammalian deacetylases or amidases, it is an attractive target for new antibacterials. The first report of LpxC inhibitors was in 1996 with the development of hydroxamate compounds that interact with the catalytic Zn 2+ ion. 60 Unfortunately, the antibacterial spectrum of these early compounds was limited due to subtle differences in LpxC structure. 61 A recent advance by McClerren et al. 62 describes the inhibition of diverse LpxC enzymes by a novel N-aroyl-L-threonine hydroxamic acid showing antibiotic activity comparable to that of Ciprofloxacin. Both the crystal and NMR structures of Aquifex LpxC have now been solved which may allow for the development of LpxC inhibitors of even greater potency. 63, 64 
Synthesis of lipid A molecules with three or four amidelinked acyl chains
Certain pathogenic bacteria, such as Leptospira, 65 Campylobacter, 66 and Legionella, 67 produce a lipid A moiety with three or four amide-linked hydroxyacyl chains. In some cases, as in Campylobacter jejuni, one of the glucosamine residues is replaced with the sugar 2,3-diamino-2,3-dideoxy-D-glucopyranose (GlcN3N) resulting in a GlcN-GlcN3N disaccharide backbone. 66 Substitution of both GlcN sugars gives a GlcN3N-GlcN3N backbone bearing four N-linked hydroxyacyl chains typified by the lipid A of Leptospira interrogans (Fig. 3 ). 65 The biochemical origin of the diamino-sugar precedes the constitutive lipid A pathway with the conversion of the UDP-GlcNAc substrate to its diaminoanalog, UDP-GlcNAcN3. Bioinformatic analysis of diverse Gram-negative bacterial genomes reveals that two open reading frames encoding a putative oxidoreductase (GnnA) and a transaminase (GnnB) are sometimes linked to the lpxA-lpxB region of the chromosome in organisms containing a diamino-disaccharide. 68, 69 Biochemical characterization of GnnA and GnnB from Acidithiobacillus ferrooxidans, an acidophilic bacterium, by Sweet and co-workers 68 confirmed the predicted function of these enzymes in the generation of UDP-GlcNAcN3 ( Fig. 3 ). Orthologs of GnnA and GnnB are present in the genomes of all Gram-negative organisms known to synthesize GlcN3N-substituted lipid A. Furthermore, organisms producing a GlcN3N-GlcN3N backbone bearing four amide linked acyl chains express a LpxA that is selective for UDP-GlcNAc3N, explaining why only diamino-sugars are incorporated into the lipid A structure of certain bacteria. 68, 69 The importance of Nlinked fatty acyl chains in pathogenesis is not clear. Still, one can speculate that an increase in the number of amide-linked acyl chains would provide further stability to the outer membrane under harsh conditions, such as elevated temperatures and extreme pH due to the greater bond strength.
Diversity in the Lpx acyltransferases
Much of the diversity seen in endotoxin structures arises from the substrate preferences of the early (LpxA and LpxD) and late (LpxL and LpxM) acyltransferases (see Fig. 4 ). Unlike acyltransferases involved in phospholipid biosynthesis, these enzymes usually have a high degree of specificity for their acyl donor with regards to fatty acyl chain length and extent of saturation. For example, LpxA is highly selective for β-hydroxymyristate (3-OH-C14:0) 70 while the LpxA of Pseudomonas aeruginosa incorporates a β-hydroxydecanoate (3-OH-C10:0) fatty acid. 71 This selectivity arises from the existence of a precise 'hydrocarbon ruler' in the LpxA structure and accounts for much of the diversity in the acylation patterns seen in different organisms. 72 The acyloxyacyl linked secondary acyl chains of lipid A are critical for the endotoxic properties of the molecule and are required for growth in some organisms. Therefore, a significant body of literature exists on the biochemical and genetic characterization of these enzymes revealing some interesting variations from the prototypical lipid A biosynthetic pathway of E. coli and Salmonella. In E. coli, both LpxL and LpxM require the Kdo disaccharide for activity and incorporation of the C12:0 acyl chain at the 2′-position by LpxL precedes the LpxM catalyzed addition of C14:0 at position 3′. 58 Conversely, the late acyltransferases of P. aeruginosa and Neisseria meningitidis do not require the Kdo disaccharide for enzymatic activity and transfer one laurate (C12:0) chain to each glucosamine unit at the 2-and 2′positions to form a more symmetrical lipid A. [73] [74] [75] Not all Gram-negative bacteria contain two late acyltransferases. The genome of Chlamydia trachomatis contains a single LpxL ortholog, 76 which is in line with the available structural data for the C. trachomatis lipid A structure, showing a single fatty acyl chain at the 2′-position. [77] [78] [79] Interestingly, certain Gram-negative bacteria such as C. jejuni, synthesize a lipid A with two secondary acyl chains but contain only a single LpxL ortholog. 80 The genome of Helicobacter also contains a single ortholog of LpxL; 81 however, a minor lipid A species that is hexa-acylated can be isolated from this organism. 82 Our laboratory has determined that H. pylori LpxL is a mono-functional acyltransferase that utilizes Kdo 2 -lipid IV A as its substrate (unpublished results, C. M. Stead and M. S. Trent). Since the genomes of Campylobacter and Helicobacter contain no other known lipid A acyltransferases, such as the outer membrane acyltransferase PagP (discussed later), these organisms must contain a novel lipid A acyltransferase that remains to be identified.
Some bacteria possess a third late acyltransferase, termed LpxP, that is induced during cold shock. 83 During growth at 12°C, E. coli LpxP adds a palmitoleate (C16:1) to the 2′-linked acyl chain replacing LpxL function. LpxP shows significant similarity to LpxL and LpxM and, like these enzymes, requires the presence of the Kdo disaccharide for enzymatic activity. The way in which the cell determines the amount of laurate or palmitoleate to be integrated into its outer membrane is unclear, but approximately 80% of the lipid A residues of cells grown at 12°C contain the unsaturated fatty acyl chain. The cold shock incorporation of the unsaturated palmitoleoyl fatty acyl chain is thought to help increase the fluidity of the outer membrane when shifted to lower temperatures. 83, 84 Yersinia pestis, the causative agent of plague, can synthesize both penta-and hexa-acylated structures at 21°C containing C16:1 fatty acyl chains. 85 However, growth at 37°C results in the production of only tetra-acylated lipid A. The decrease in fatty acylation of Y. pestis LPS at 37°C, the temperature of its mammalian host, most likely aids the bacterium in evading the innate immune response since activation of human TLR4 requires the presence of secondary acyl chains. 17 Yersinia enterocolitica and Yersinia pseudotuberculosis can also incorporate C16:1 into their lipid A domains during growth at lower temperatures. 85 
Transport
The core oligosaccharide of LPS, which includes the Kdo sugars, is attached to the lipid A domain on the cytoplasmic side of the inner membrane. Core-lipid A must then be translocated across the inner membrane where the O-antigen domain is attached, completing LPS assembly. 2 Transport of core-lipid A across the inner membrane requires the ABC transporter, MsbA (Fig. 2 ). 86, 87 MsbA is highly conserved in Gram-negative bacteria and shares homology with the multidrug resistance (MDR) proteins of eukaryotes. In E. coli, MsbA is essential for growth and inactivation of the transporter in temperature-sensitive mutants results in the accumulation of lipid A and glycerophospholipids in the inner membrane. 86 The ATPase activity of purified MsbA reconstituted in liposomes has been investigated and is stimulated by lipids and especially by Kdo 2 -lipid A. 88 Unfortunately, attempts to demonstrate MsbA flippase activity in phospholipid vesicles have not been successful and remain a major challenge in LPS research. However, utilizing the enzymatic modification of lipid A as a marker for membrane topology, the MsbA-dependent trans-bilayer movement of newly synthesized corelipid A across the inner membrane has been confirmed in vivo. 89 X-ray structures are available for E. coli 90, 91 and Vibrio cholerae 92 MsbA and support the role of this protein in the transport of LPS. The role that MsbA plays in the flip-flop of glycerophospholipids of various Gram-negative bacteria is still uncertain. Surprisingly, encapsulated N. meningitidis harboring an lpxA mutation remain viable even upon complete loss of endotoxin from the cell. 93 Loss of MsbA transport in these organisms does not result in cell death or the loss of outer membrane biogenesis. 94 These data suggest that the accumulated phospholipids reported in E. coli during loss of MsbA function 86 may occur only as a secondary effect to inhibition of LPS transport.
The way in which LPS is translocated to the outer leaflet of the outer membrane is largely unknown, but recently several studies have shed light on this process. Omp85, an essential outer membrane protein, was first identified in N. meningitidis and originally implicated in the export of outer membrane lipids. 95 Further investigation of Omp85 and its E. coli ortholog, YaeT, suggests that Omp85 is not required for LPS transport but rather for the assembly of outer membrane proteins. [96] [97] [98] YaeT exists in a hetero-oligomeric outer membrane complex with the lipoproteins YfiO, NlpB, and YfgL. 99 A second essential outer membrane protein, known as Imp (OstA), was found to be necessary for the transport of LPS from the periplasmic leaflet of the inner membrane to the bacterial cell surface. 100 Outer membrane permeability defects in an E. coli mutant expressing the Imp protein with a 23 amino acid deletion can be partially restored by null mutations in yfgL. 101 Taken together, these biochemical and genetic studies demonstrate a connection between protein and lipid transport in the biogenesis of the outer membrane.
Modification of the lipid A domain of LPS
Since LPS is a major surface molecule and a primary virulence determinant of Gram-negative bacteria, it is not surprising that bacteria have evolved mechanisms to modify their LPS structure in order to promote their survival. Variation of the lipid A domain can occur on both the hydrophilic disaccharide region and the hydrophobic acyl chain region. Figure 4 illustrates the diversity seen in the lipid A structures synthesized by various pathogens. How these alterations are regulated and the number and type of modifications vary for each bacterial species. 31 In general, modification of lipid A occurs at the periplasmic face of the inner membrane or in the outer membrane, allowing for separation of the constitutive lipid A pathway from the latent modifications. This separation may be important to maintain efficient synthesis of lipid A and, perhaps, to ensure proper transport by MsbA across the inner membrane.
We have known for many years that Gram-negative bacteria could synthesize LPS with additional substituents, but only recently has the origin of these modifications been elucidated. A groundbreaking discovery in 1997 reported by the laboratory of Samuel I. Miller showed that lipid A modifications in Salmonella were under the control of PhoP-PhoQ, 102 a two component regulatory system essential to Salmonella virulence. The effects of modifying the lipid A structure are generally 2-fold: (i) to promote resistance to host cationic antimicrobial peptides (CAMPs) that are mobilized shortly after host infection to destroy invading microbes; and (ii) to evade recognition by the innate immune receptor, TLR4. Table 1 summarizes the distribution of lipid A modifying enzymes in human pathogens and the role these modifications are thought to play in bacterial pathogenesis.
Diversity in lipid A acylation
For some Gram-negative bacteria, extracellular signals are needed to cue the bacterium to modify lipid A structure. In the case of Salmonella, the PhoP-PhoQ system is activated following phagocytosis by macrophages 103 alerting the bacterium to its presence inside the phagolysosome and leading to the activation or repression of over 40 loci. 104 In the laboratory, the PhoP-PhoQ system can be activated during exposure of the bacterium to CAMPs 105, 106 or during Mg 2+ limitation. 107 A number of PhoP-activated genes, designated as pag(s), encode for outer membrane proteins some of which modify the lipid A structure. PagP and PagL are both small outer membrane enzymes that alter the acylation pattern of lipid A. PagP, a palmitoyl transferase, was originally identified in Salmonella as a protein that is important for resistance to certain CAMPs. 108 Presumably, the addition of palmitate to lipid A results in a more tightly packed LPS, thereby increasing the integrity of the outer membrane and preventing peptide insertion. PagL is a PhoP-activated lipase that removes the 3-O-linked acyl chain of lipid A 109 and appears to play no role in antimicrobial peptide resistance. Modification of the acylation pattern of Salmonella lipid A by either PagP or PagL results in attenuation of lipid A signaling through the TLR4 pathway and, therefore, may promote evasion of the innate immune system during infection. [110] [111] [112] A number of Gram-negative organisms contain homologs of PagP including Shigella flexneri, E. coli, Legionella pneumophila and species of Bordetella and Yersinia. 113 For a recent, excellent review on the palmitoylation of lipid A, see Bishop. 113 Similar to Salmonella, loss of PagP function in Legionella results in the sensitivity to certain CAMPs. In addition, Legionella pagP is important for intracellular infection and virulence. 114 In Bordetella bronchiseptica, pagP is required for persistence in the mouse respiratory tract, and palmitoylation of Bordetella lipid A provides resistance to antibody-mediated complement lysis. 115, 116 PagP has been well characterized in both E. coli and Salmonella, and the structure of PagP has been determined by both NMR spectroscopy and X-ray crystallography. [117] [118] [119] [120] In E. coli and Salmonella, PagP transfers a palmitate from glycerophospholipids to the 2-position of the proximal glucosamine of lipid A to form an acyloxyacyl linkage resulting in a hepta-acylated structure. 121 PagP of B. bronchiseptica incorporates a C16:0 chain at the 3′-position producing a hexa-acylated structure. 116 The lipid A of Bordetella contains only one late acyl chain at the 2′-position, leaving the hydroxyl group of the primary acyl chain at the 3′-position available for substitution by PagP. P. aeruginosa, an opportunistic pathogen, also modifies its lipid A with a C16:0 at the 3-position of the molecule. 122 The addition of palmitate to Pseudomonas lipid A is seen in laboratory strains under PhoP-activating conditions and is also present in strains isolated from cystic fibrosis patients. 122 Although in vitro assays confirm that a PagP-like enzyme is present in membranes of P. aeruginosa (Trent MS, unpublished observation), there is no PagP homolog identified in the genome of this organism. 123 Also of interest is the possibility that the addition of palmitate to different locations on the lipid A molecule may lead to distinct phenotypes important for virulence. For example, in enteric organisms, PagP transfers a palmitate to the 2-position and clearly plays a role in CAMP resistance. 108 In contrast, it has been reported that Bordetella pagP mutants do not show increased sensitivity to certain CAMPs, 116 and a similar result has been reported for PhoP null mutants of Pseudomonas lacking palmitoylated lipid A. 122 A detailed analysis of how the site of palmitoylation effects CAMP resistance, complement evasion, and modulation of TLR4 activation would be beneficial. The molecular weight (MW) given for outer membrane proteins was adjusted for removal of the signal peptide. b LpxE was originally discovered in the nitrogen-fixing symbiotic bacterium Rhizobium leguminosarum. c The lipid A structure of the organism predicts the described modification, but no clear homolog exists in genome.
Like PagP, the outer membrane deacylase PagL was originally described in Salmonella. 109 Recently, homologs of PagL have been reported in species of Pseudomonas, Bordetella, and Burkholderia. 124, 125 The role of PagL in these organisms is unclear and S. typhimurium lacking pagL display no obvious phenotypes in a murine model. 126 Although PagL is under the control of PhoP, the deacylase does not appear to be active in the outer membrane of Salmonella when grown under Mg 2+ -limiting conditions. 102 Kawasaki et al. 127 reported that PagL appears to be activated in mutants of Salmonella that were unable to modify their lipid A with L-Ara4N, suggesting that the deacylase is post-translationally inhibited within the outer membrane.
Previous investigations of the lipid A domains from other pathogens, such as H. pylori 82, 128 and Y. enterocolitica 85 revealed the absence of ester-linked acyl chains at the 3′-position, suggesting these organisms possess unidentified lipid A deacylases as well. Reynolds and co-workers just reported the discovery of LpxR, 129 an outer membrane enzyme that catalyzes the removal of the 3′-acyloxyacyl moiety of Salmonella lipid A (Fig. 1) . LpxR is not dependent on PhoP activation but does require the divalent cation Ca 2+ for enzymatic activity. This discovery was somewhat of a surprise given that Salmonella lipid A is not appreciably 3′-O-deacylated under diverse growth conditions. Orthologs of Salmonella LpxR can be found in the genomes of various Gram-negative bacteria including H. pylori, Y. enterocolitica, E. coli O157:H7, and V. cholerae. 129 Similar to Salmonella PagL, LpxR remains inactive within the Salmonella outer membrane unless the enzyme is overexpressed. On the contrary, H. pylori LpxR appears to be activated since the major lipid A species of H. pylori is completely 3′-O-deacylated. 82, 128 How the activity of the lipid A deacylases is governed within the outer membrane of diverse Gram-negative bacteria is a fascinating question that is currently under investigation.
Finally, it is noteworthy to mention that in some organisms the pagP and/or pagL genes have been inactivated. The pagP gene of Y. pestis contains a premature stop codon that is predicted to result in a non-functional protein, 113, 130 and B. pertussis pagP has been inactivated by the insertion of a transposable genetic element in the promoter region. 131 Curiously, B. pertussis has also lost a functional copy of the pagL gene, whereas, the pagL genes of Bordetella species bronchiseptica and parapertussis are functional. 124, 131 Perhaps these outer membrane modifications were lost in some organisms to promote adaptation to their specific hosts.
An additional modification to the hydrophobic region of the lipid A domain is the generation of 2-hydroxylated fatty acyl chains. The presence of a 2-OH myristate group at the 2′-position of Salmonella lipid A was originally reported to occur during activation of PhoP. 102 However, it was recently demonstrated that 2-hydroxymyristate modification of S. typhimurium lipid A is largely independent of the PhoP-PhoQ system and is lost only upon mutation of the lpxO gene. 132 The latter encodes for a putative aspartyl/asparaginyl β-hydroxylase responsible for the direct hydroxylation of lipid A. 133 LpxO is an inner membrane protein and hydroxylation of lipid A is independent of MsbA transport, indicating a cytoplasmic active site for the enzyme. 89 In support of earlier work, the transcription of lpxO is increased several fold during PhoP activation. Nonetheless, basal transcription levels of lpxO must be sufficient to support hydroxylation of Salmonella lipid A under all growth conditions. 132 PhoP-null mutants of P. aeruginosa still retain hydroxylated acyl chains, again, supporting that hydroxylation of lipid A is not solely dependent upon PhoP-activation. 122 Unfortunately, there are no published reports as to whether or not hydroxylation of lipid A by LpxO is necessary for virulence.
Diversity in lipid A phosphorylation
Modification to the disaccharide backbone of lipid A centers on the removal or decoration of the lipid A phosphate groups. In some Gram-negative bacteria, such as E. coli and Salmonella, this includes the addition of the amine-containing residues 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine (pEtN). 2, 31, 134 Masking of the lipid A phosphate groups with these positively charged moieties results in resistance to CAMPs and to polymyxin, a cyclic antimicrobial lipopeptide produced by Gram-positive bacteria. The polymyxinresistant phenotype of S. typhimurium is primarily under the control of the PmrA/PmrB two-component regulatory system that is activated during growth under conditions of low pH, high Fe 3+ , and also by PhoP. [135] [136] [137] The presence of L-Ara4N in the LPS of Salmonella (Fig. 1 ) was first reported in 1970, 138, 139 but only recently has the biochemical mechanism for L-Ara4N addition been defined. PmrA activation of the pmrE (ugd) and the pmrHFIJKLM (also referred to as arn 139 ) genes results in the synthesis and attachment of the L-Ara4N moiety to lipid A (reviewed by Trent 31 and Bishop 133 ). Transfer of L-Ara4N to lipid A occurs in the periplasm and is catalyzed by ArnT (PmrK), an enzyme displaying distant similarity to yeast protein mannosyltranferases. 140 The periplasmic localization of L-Ara4N transfer is supported by the fact that ArnT utilizes undecaprenyl phosphate-α-L-Ara4N as its sugar donor, 141 and that the loss of lipid A transport across the inner membrane results in the loss of the modification. 89 Homologs of ArnT are present in other pathogenic organisms known to synthesize L-Ara4N modified lipid A including E. coli, P. aeruginosa, Y. pestis, Proteus mirabilis, and Brucella abortus. A clear correlation between CAMP resistance and L-Ara4N modification has been demonstrated in several organisms. [142] [143] [144] [145] [146] Furthermore, S. typhimurium mutants unable to modify their lipid A with L-Ara4N show reduced virulence compared to wild-type strains when administered orally to BALB/c mice indicating the importance of this modification. 146 The transfer of pEtN to the lipid A disaccharide requires the inner membrane enzyme EptA, also known as PmrC. 147, 148 Like ArnT, modification to the phosphate groups of lipid A by EptA occurs on the periplasmic side of the inner membrane where the enzyme utilizes phosphatidylethanolamine as the pEtN donor. 147, 148 Expression of EptA (PmrC) is under the control of PmrA, and the EptA-encoding gene is part of the pmrAB operon. 147, 149 Addition of pEtN groups to the lipid A disaccharide occurs in a large number of human pathogens but the role in which pEtN modification plays in CAMP resistance is not clear. For example, Salmonella eptA (pmrC) mutants unable to modify their lipid A with pEtN show only slight increases in susceptibility to killing by polymyxin (less than 5-fold) 147, 150 and show no virulence defects using a mouse model. 150 Since Salmonella is known to contain lipid A species modified at both the 1-and 4′-phosphates with L-Ara4N, 151, 152 it is possible that loss of EptA function would result in increased L-Ara4N substitution in the phagolysosome. Relative to Salmonella, pEtN modification of E. coli lipid A is much higher 132, 153 but polymyxin sensitivity of an E. coli EptA mutant has not been tested.
N. meningitidis does not possess the enzymatic machinery to produce L-Ara4N modified lipid A (Fig.  4 ), yet this organism is intrinsically highly resistant to CAMPs. Loss of LptA function, the neisserial homolog of EptA, results in more than a 200-fold reduction in polymyxin 154, 155 showing that addition of pEtN to the phosphate groups of meningococcal lipid A is critical for resistance to polymyxin and other CAMPs. 155 We have observed a dramatic reduction in CAMP resistance in an H. pylori mutant unable to modify its lipid A with pEtN. 156 . It should be noted, however, that the pEtN unit found in H. pylori lipid A is attached directly to the C-1 hydroxyl group (Fig. 4) , 82 rather than attached to the lipid A phosphate group. In the case of H. pylori, a lipid A phosphatase functions prior to Helicobacter EptA. 157 Removal of the phosphate group prior to pEtN addition in H. pylori results in a greater negative charge reduction to the outer surface of this organism. Other organisms, such as V. cholerae, 158, 159 C. jejuni 66 and P. gingivalis 160, 161 produce lipid A species containing either one or two pEtN groups but are unable to modify their lipid A with L-Ara4N (Fig. 4) . In Gram-negative bacteria other than E. coli and Salmonella, it is unclear if pEtN modification is a regulated event since pEtN addition occurs under standard growth conditions in the labora-tory. Further investigation of pEtN modification in other pathogens will be required to determine its role in CAMP resistance and pathogenesis.
Interestingly, Leptospira interrogans, the spirochete responsible for the zoonotic disease leptospirosis, modifies the 1-phosphate moiety of its lipid A with a methyl group. 65, 162 The membrane enzyme LmtA transfers a methyl group from S-adenosylmethionine (SAM) to the 1-phosphate group of leptospiral lipid A on the cytoplasmic side of the inner membrane. Methylation of phosphate groups is a rare occurrence in biological systems and the methylation of lipid A appears to be exclusive to Leptospira. 162 A novel modification specific for Francisella tularensis is the capping of the 1-phosphate group with a galactosamine residue. 163 Addition of this amine-containing sugar resembles L-Ara4N addition in other bacteria and, as one might expect, the sequenced genome of F. tularensis contains a homolog of ArnT. 164 The impact these modifications has on pathogenesis is unclear.
Although the enzymatic steps to produce a bis-phosphorylated lipid A are well conserved, a number of pathogenic organisms, including H. pylori, 16, 82 P. gingivalis, 160, 161 B. fragilis, 165 L. interrogans, 65 and F. tularensis, 163, 166 lack one or both phosphate groups from their lipid A anchors. Removal of the lipid A phosphate groups may prove to be beneficial for the bacterium during infection by reducing the endotoxic properties of lipid A, while at the same time reducing its affinity for antimicrobial peptides. The enzymatic dephosphorylation of lipid A was first demonstrated in the nitrogen-fixing Gram-negative endosymbiont, Rhizobium leguminosarum. 167 Later, the 1-phosphatase of Rhizobium, known as LpxE, was cloned 168 and homologs from both Helicobacter 157 and Francisella 169 have been characterized. Furthermore, a lipid A 4′-phosphatase, termed LpxF, has been expression-cloned and characterized in F. novicida. An ortholog of LpxF is present in the genome of R. leguminosarum, 170 but not in the genomes of other Gram-negative bacteria known to synthesize 4′-dephosphorylated lipid A. 170 Interestingly, Francisella LpxF cannot dephosphorylate hexa-acylated lipid A containing a secondary 3′-acyl chain, but rather prefers a penta-acylated substrate. 170 We have observed that H. pylori membranes efficiently catalyze the removal of the 4′-phosphate group from hexa-acylated lipid A (Tran AX and Trent MS, unpublished observation). Both H. pylori and L. interrogans are capable of synthesizing hexa-acylated lipid A species. Therefore, it has been proposed that these organisms express a unique 4′-phosphatase capable of accommodating a 3′-linked secondary acyl chain. 170 The characterized lipid A phosphatases contain a periplasmic active site since dephosphorylation is dependent upon translocation of lipid A across the inner membrane. Although not confirmed by site-directed mutagenesis, LpxE contains a tri-partite active site motif (KX 6 RP, PSGH, and SRX 5 HX 3 D) shared among several lipid phosphatases, including E. coli phosphatidylglycerol phosphatase (PgpB). 171 A similar tri-partite active site is found in LpxF, but with substitutions of key amino acids of predicted catalytic importance. Members of the family Enterobacteriaceae do not appear to express lipid A phosphatases, which is supported by the numerous lipid A structures reported for these organisms. Shi and co-workers 172 have reported the identification of the inner membrane protein UgtL that promotes the dephosphorylation of Salmonella lipid A in a PhoP-dependent manner, thus helping to increase resistance to both polymyxin and magainin 2. However, other laboratories have not observed PhoP-regulated dephosphorylation of Salmonella lipid A or reported a Salmonella lipid A phosphatase activity. Identification of phosphatases in other Gram-negative bacteria and the generation of specific mutants are required to determine the biological significance of synthesizing phosphate-deficient lipid A anchors.
Modification of the Kdo-heptose region of LPS
Similar to the lipid A domain of LPS, the core region is also subject to structural modifications. Before transport across the inner membrane, the Kdo-lipid A domain of LPS is extended with the addition of the core oligosaccharide. Typically, the inner core of Gram-negative bacterial LPS possesses some number of L-glycero-D-manno-heptose sugars linked to the conserved Kdo. 2 The heptose sugars can be further derivatized with phosphoryl substituents that are critical for the formation of a stable outer membrane. Addition of these negative charges on the inner core allows for bridging of neighboring LPS molecules by divalent cations, such as Ca 2+ and Mg 2+ , resulting in a less fluid and more stable outer membrane. 173 Phosphorylation of the innermost heptose sugar (attached to Kdo) requires the kinase WaaP, whereas, WaaY catalyzes phosphorylation of the second heptose ( Fig. 1) . 174 The first report of a regulated modification to the core region of LPS was the discovery of EptB, a Ca 2+ -induced enzyme responsible for a pEtN substitution on the outer Kdo sugar (Fig. 1 ) of E. coli and Salmonella LPS. 175, 176 EptB shares homology to the lipid A pEtN transferase, EptA, but its expression is not regulated by PmrA. The loss of EptB function results in hypersensitivity to Ca 2+ in E. coli mutants producing heptose-deficient LPS. Conversely, mutants in strains synthesizing a complete core are no longer Ca 2+ -sensitive. 176 Recently, Tamayo et al. 150 identified a PmrA-regulated gene, cptA, involved in modification of the inner core with pEtN. Based upon structural studies of the core domain of cptA mutants, this enzyme most likely transfers a pEtN to the phosphate group added by WaaP on the innermost heptose ( Fig. 1) . Although pEtN modification of the LPS core is increased in polymyxin-resistant mutants of Salmonella, 150, 177 cptA mutants display only a minor increase in polymyxin sensitivity and show essentially no loss in virulence. 150 CptA shares homology to other pEtN transferases involved in LPS biosynthesis including, EptA, EptB, and Lpt-3. Lpt-3 is required for pEtN addition to the distal heptose sugar of the inner core region of Neisseria LPS. 178 Two additional enzymes that modify the inner core region of LPS are the Kdo kinase and a recently reported Kdo-trimming enzyme. Because of the remarkable functionality of the various Kdo transferases, the number of Kdo sugars differs in Gram-negative organisms. Typically, organisms having a single Kdo sugar in their inner core, such as H. influenzae, 179, 180 V. cholerae 158 and B. pertussis, 181 phosphorylate their Kdo. Phosphorylation occurs at the 4-OH position, the same site at which the second Kdo residue is attached in most Gramnegative bacteria, and is catalyzed by KdkA. 182, 183 Loss of Kdo phosphorylation in kdkA mutants of Haemophilus results in loss of virulence in an infant rat model. 184 What role this modification plays during pathogenesis is unknown, but homologs of KdkA can be identified in organisms with a phosphorylated Kdo. 183 It should be noted that phosphorylation of the single Kdo sugar of LPS also occurs at position 5; 180,185 however, it does not appear that KdkA is required for this event 182 suggesting an additional unidentified Kdo kinase.
The inner core region of H. pylori LPS contains a single Kdo sugar, 186 predicting a monofunctional Kdo transferase. In spite of this, biochemical characterization of H. pylori WaaA demonstrated the enzyme to be bifunctional in nature. 187 Instead, the origin of the single Kdo sugar in LPS arises from the action of a specific Kdotrimming enzyme that removes the outer Kdo. 187 Therefore, the number of Kdo sugars in the core oligosaccharide of LPS does not conclusively predict the functionality of WaaA. A putative Kdo-trimming enzyme has also been reported in membranes of F. novicida, an organism with a single Kdo sugar in its core. 166, 169 The structural gene encoding this unique enzyme is still unknown and, therefore, mutants are not yet available to help determine the advantage of removing the outer Kdo sugar. Although the lipid A domain is most critical for LPS toxicity, variations in the core oligosaccharide may play a part in activation of the innate immune system. The Kdo sugars of lipooligosaccharide were shown to be important for activation of human and murine macrophages via the TLR4/MD-2 pathway. 188 Finally, removal of the outer Kdo sugar may help provide resistance to CAMPs, since this modification would result in the reduction of negative charges.
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CONCLUDING REMARKS
The completion of the lipid A biosynthetic pathway along with advances in microbial genomics have led to the conclusion that Gram-negative organisms synthesize their lipid A via a conserved pathway. However, LPS is a dynamic molecule and the ability of Gram-negative bacteria to modify its structure represents one mechanism used to remodel the bacteria's cell surface. To date, over 16 different enzymes have been identified that modify the inner core and lipid A domains of LPS, some of which are summarized in Table 1 . The diverse biochemical structures arising from these enzymes are quite remarkable and allow for the possibility of different chemical subtypes of lipid A to be expressed on the outer surface of the bacterium simultaneously.
In some organisms, modifications to the lipid A structure are regulated by two-component regulatory systems in response to specific environmental stimuli that can be mimicked in the laboratory. Other bacteria appear to modify their lipid A constitutively. However, it cannot be ruled out that the host environment provides specific signals for some pathogens to modulate between different lipid A species that cannot be replicated under standard laboratory conditions. Recently, Gibbons and co-workers 132 isolated the lipid A of S. typhimurium grown in macrophages confirming the structural modifications reported for this organism. Although challenging, other studies of this type with various pathogens would be of interest. Finally, there is also evidence that certain modifications are regulated at the post-translational level such as the suppression of S. typhimurium PagL activity by the presence of L-Ara4N 127 or the requirement of 1-dephosphorylation of H. pylori lipid A for the efficient removal of the outer Kdo. 187 Along these lines, loss of myristoylation of E. coli or S. typhimurium lipid A by inactivation of lpxM results in the loss of L-Ara4N addition and polymyxin resistance. 189 Enormous progress has been made in understanding the molecular mechanisms of LPS modification. However, the synthesis of diverse endotoxin structures is a complex process. Although different bacteria share similar structural modifications, these modifications may not always have the same influence on pathogenesis. For example, pEtN modification of Neisseria lipid A is critical for CAMP resistance 155 whereas pEtN modification in Salmonella is not. 147, 150 PagP palmitoylates lipid A at the 2-position of enteric organisms but not in other bacteria. Considerable attention has been focused on how lipid A modifications effect CAMP resistance and activation of Toll-like receptors. Still, it is important to remember that modification of the Kdo-lipid A structure will effect both the permeability and stability of the outer membrane barrier. 173 Other possible effects include the folding of outer membrane proteins, the degree of shedding of outer membrane vesicles, and even the secretion of toxins. 190, 191 The discovery of the origin of diverse endotoxin structures will continue to be an important and beneficial part of LPS research. Understanding the biochemistry of lipid A modifications and their impact on pathogenesis could lead to novel treatment options during Gram-negative bacterial infections. Although beyond the scope of this review, a fruitful part of endotoxin research has been the development of modified lipid A structures as immune adjuvants and for use as endotoxin antagonists. 192, 193 Identification of additional modifying enzymes will continue to allow researchers to explore unique lipid A structures as modulators of the immune system.
